Crossover RCT in 61 patients with mild-to-severe COPD without hypoxaemia or pulmonary hypertension: inhaled nitric oxide vs placebo did not significantly change peak VO2 (0.36 mL/kg/min). In prespecified analyses, greater small-vessel volume predicted better response.
RCTn = 61
Collins et al. A Randomized, Placebo-Controlled, Double-Blind, Crossover Trial of Inhaled Nitric Oxide in Patients With Mild-to-Severe COPD